PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Apr 2005 (Vol:2005, Issue: 58)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
The Value of Valuations Published: 1 Apr-2005
By: Fintan Walton
Abstract Fulltext:
Section: Deal Trackers
Bioenvision Published: 5 Apr-2005
By: Business Review Editor
Abstract
Section: Distribution & Marketing
Mayne Pharma and PLIVA Enter Strategic Biogeneric Partnership for EPO and G-CSF Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Takeda and 3M Target HPV and Future Growth Published: 1 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Vertex Opts for Avalon to Progress VX-944 Published: 1 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Product Sale and Purchase Agreements Published: 1 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Acne Published: 1 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Andrx Exits the Branded Drugs Business Published: 5 Apr-2005
By: Business Review Editor
Abstract
De Novo Pharmaceuticals Ltd Published: 5 Apr-2005
By: Business Review Editor
Abstract
Section: Licensing
Sosei In-Licenses Otsuka’s Urology Drug Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Osei Acquires Exclusive Rights to Bacterial Therapeutic from Miyarisan Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Mylan and King Terminate Merger Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Novartis Expands Generics Business Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Biogen and Elan Lose Market Value as Tysabri® Withdrawn Published: 5 Apr-2005
By: Business Review Editor
Abstract Fulltext:

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Table of Contents

Login

Bookmarks